Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Concarlo Therapeutics logo — Developing solutions for drug-resistant cancer

Concarlo Therapeutics

Developing solutions for drug-resistant cancer

Founded 2016 United States Brooklyn, United States 15 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Concarlo Therapeutics
Founded Year 2016
Location United States Brooklyn, United States
Employees 15
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Concarlo Therapeutics. To contact Concarlo Therapeutics, visit concarlo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Concarlo Therapeutics

Founded in July 2016 and headquartered in Brooklyn, New York, Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1. Concarlo's novel IpY therapeutic will be the first inhibitor to solve the CDK2 resistance issue, the first therapeutic to target p27 and the first to inhibit CDK4 and CDK2 simulataneously.

No funding data available for Concarlo Therapeutics yet.

Concarlo Therapeutics Alternatives & Competitors

Concarlo Therapeutics vs
ORIC Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc. United States

Overcoming Resistance In Cancer

Post-IPO Equity
119 employees
Biopharma, Biotechnology
Concarlo Therapeutics vs
Senex Biotechnology. Inc.
Senex Biotechnology. Inc.

Preventing Adaptive Drug Resistance and Cancer Metastasis

Debt Financing
5 employees
Biotechnology, Health and Wellness
Concarlo Therapeutics vs
Flare Therapeutics
Flare Therapeutics United States

Trailblazing the path to drugging transcription factors to discover precision medicines for cancer &...

Series B
62 employees
Biopharma, Biotechnology

FAQ About Concarlo Therapeutics

Developing solutions for drug-resistant cancer
Concarlo Therapeutics was founded in 2016.
Concarlo Therapeutics is headquartered in Brooklyn, United States.
Concarlo Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
Concarlo Therapeutics has approximately 15 employees.
Top alternatives and competitors to Concarlo Therapeutics include ORIC Pharmaceuticals Inc., Senex Biotechnology. Inc., Flare Therapeutics, Prescient Therapeutics, HiberCell. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Concarlo Therapeutics and ORIC Pharmaceuticals Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Concarlo Therapeutics, https://bouncewatch.com/company/concarlo-therapeutics, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes